Company / CapEx per Share
Corbus Pharmaceuticals Holdings, Inc. CapEx per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2022
5-year range
$0.00 / $0.04
FY2018-FY2022
Trend
+165.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.04 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2022 with a 5-year CAGR of +33.8%.
Declined from $0.04 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- +33.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capex per share increased 165.1% year-over-year.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.01 | +165.1% |
| FY2021 | $0.00 | -88.4% |
| FY2020 | $0.04 | +5.5% |
| FY2019 | $0.04 | +215.8% |
| FY2018 | $0.01 | +319.5% |
| FY2017 | $0.00 | +0.0% |
| FY2016 | $0.00 | +22.0% |
| FY2015 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026